Target Price | $6.00 |
Price | $2.93 |
Potential |
104.78%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a CASI Pharmaceuticals Inc price target 2025.
The average CASI Pharmaceuticals Inc target price is $6.00.
This is
104.78%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend CASI Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CASI Pharmaceuticals Inc stock has an average upside potential 2025 of
104.78%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 33.88 | 19.80 |
10.96% | 41.57% | |
Net Margin | -79.89% | -102.22% |
24.63% | 27.94% |
1 Analyst has issued a sales forecast CASI Pharmaceuticals Inc 2024 . The average CASI Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.02 | -1.51 |
32.89% | 25.25% | |
P/E | negative | |
EV/Sales | 4.69 |
Based on analysts' sales estimates for 2024, the CASI Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
CASI Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.